Investing.com - Zimmer Biomet reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Zimmer Biomet announced earnings per share of $1.71 on revenue of $1.85B. Analysts polled by Investing.com anticipated EPS of $1.53 on revenue of $1.76B.
Zimmer Biomet shares are up 15% from the beginning of the year, still down 1.20% from its 52 week high of $180.11 set on April 29. They are outperforming the S&P 500 which is up 11.62% from the start of the year.
Zimmer Biomet follows other major Healthcare sector earnings this month
Zimmer Biomet's report follows an earnings beat by J&J on April 20, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on April 20 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar